| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 23 | 2023 | 1426 | 3.170 |
Why?
|
| Prostatic Neoplasms | 19 | 2023 | 794 | 1.910 |
Why?
|
| Mammography | 6 | 2019 | 176 | 1.800 |
Why?
|
| Papillomavirus Infections | 6 | 2017 | 316 | 1.570 |
Why?
|
| Diabetes Mellitus | 5 | 2019 | 465 | 1.530 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2023 | 528 | 1.530 |
Why?
|
| Papillomavirus Vaccines | 4 | 2017 | 136 | 1.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2021 | 790 | 1.310 |
Why?
|
| Patient Education as Topic | 5 | 2019 | 207 | 1.300 |
Why?
|
| Female | 75 | 2023 | 19873 | 1.170 |
Why?
|
| Adult | 54 | 2022 | 11034 | 1.130 |
Why?
|
| Humans | 103 | 2023 | 34853 | 1.130 |
Why?
|
| Aged | 35 | 2022 | 6448 | 1.090 |
Why?
|
| Middle Aged | 43 | 2022 | 9642 | 1.080 |
Why?
|
| Attitude to Health | 3 | 2019 | 311 | 1.000 |
Why?
|
| Case-Control Studies | 21 | 2022 | 1056 | 0.910 |
Why?
|
| Breast | 2 | 2021 | 134 | 0.850 |
Why?
|
| Risk Factors | 24 | 2023 | 3414 | 0.830 |
Why?
|
| Reproductive History | 1 | 2021 | 18 | 0.810 |
Why?
|
| Obesity | 7 | 2022 | 965 | 0.790 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 271 | 0.780 |
Why?
|
| Postmenopause | 3 | 2019 | 125 | 0.750 |
Why?
|
| Child Abuse | 1 | 2021 | 60 | 0.740 |
Why?
|
| Male | 52 | 2023 | 18870 | 0.720 |
Why?
|
| Cross-Sectional Studies | 19 | 2023 | 2561 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2017 | 592 | 0.720 |
Why?
|
| Texas | 12 | 2015 | 299 | 0.710 |
Why?
|
| Poverty Areas | 1 | 2018 | 37 | 0.670 |
Why?
|
| Genetic Testing | 1 | 2019 | 71 | 0.660 |
Why?
|
| Mammary Glands, Human | 2 | 2015 | 39 | 0.630 |
Why?
|
| Cohort Studies | 13 | 2022 | 1422 | 0.620 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 531 | 0.610 |
Why?
|
| Early Detection of Cancer | 7 | 2022 | 292 | 0.600 |
Why?
|
| Multifactorial Inheritance | 3 | 2021 | 14 | 0.600 |
Why?
|
| Pregnancy, Unplanned | 2 | 2007 | 28 | 0.570 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2017 | 248 | 0.560 |
Why?
|
| Aftercare | 1 | 2015 | 18 | 0.550 |
Why?
|
| Odds Ratio | 9 | 2021 | 517 | 0.540 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 446 | 0.530 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 336 | 0.530 |
Why?
|
| Adolescent | 20 | 2017 | 5035 | 0.530 |
Why?
|
| Southeastern United States | 5 | 2022 | 48 | 0.530 |
Why?
|
| Tennessee | 6 | 2020 | 59 | 0.520 |
Why?
|
| Genetic Loci | 4 | 2021 | 70 | 0.520 |
Why?
|
| Social Marketing | 1 | 2014 | 22 | 0.490 |
Why?
|
| Energy Metabolism | 1 | 2015 | 160 | 0.480 |
Why?
|
| Culture | 2 | 2018 | 162 | 0.480 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 1003 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2023 | 638 | 0.440 |
Why?
|
| Child | 8 | 2023 | 2875 | 0.430 |
Why?
|
| Health Status Indicators | 3 | 2010 | 73 | 0.420 |
Why?
|
| Registries | 5 | 2015 | 330 | 0.420 |
Why?
|
| Dementia | 2 | 2003 | 133 | 0.410 |
Why?
|
| Prospective Studies | 5 | 2021 | 1353 | 0.410 |
Why?
|
| Mexico | 6 | 2015 | 223 | 0.410 |
Why?
|
| Domestic Violence | 3 | 2008 | 24 | 0.390 |
Why?
|
| Risk | 5 | 2019 | 256 | 0.390 |
Why?
|
| Intention | 2 | 2017 | 84 | 0.390 |
Why?
|
| Body Mass Index | 8 | 2022 | 775 | 0.380 |
Why?
|
| Breast Feeding | 2 | 2010 | 105 | 0.370 |
Why?
|
| Receptors, Progesterone | 3 | 2022 | 78 | 0.370 |
Why?
|
| Premenopause | 4 | 2022 | 103 | 0.360 |
Why?
|
| Risk Assessment | 8 | 2023 | 727 | 0.360 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 2333 | 0.360 |
Why?
|
| Fathers | 2 | 2010 | 26 | 0.350 |
Why?
|
| Pregnancy | 16 | 2013 | 1503 | 0.350 |
Why?
|
| Receptor, erbB-2 | 3 | 2022 | 122 | 0.350 |
Why?
|
| United States | 12 | 2022 | 3894 | 0.340 |
Why?
|
| Papillomaviridae | 1 | 2009 | 125 | 0.340 |
Why?
|
| Health Promotion | 2 | 2014 | 588 | 0.330 |
Why?
|
| Proportional Hazards Models | 5 | 2020 | 423 | 0.320 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2017 | 375 | 0.320 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 964 | 0.320 |
Why?
|
| Qualitative Research | 6 | 2023 | 393 | 0.310 |
Why?
|
| South Carolina | 7 | 2006 | 19 | 0.300 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 145 | 0.300 |
Why?
|
| Adiposity | 3 | 2017 | 145 | 0.290 |
Why?
|
| Young Adult | 7 | 2021 | 4012 | 0.290 |
Why?
|
| Incidence | 4 | 2018 | 882 | 0.280 |
Why?
|
| Pregnancy, Unwanted | 2 | 2005 | 10 | 0.280 |
Why?
|
| Focus Groups | 4 | 2020 | 307 | 0.280 |
Why?
|
| Health Education | 2 | 2020 | 304 | 0.270 |
Why?
|
| Risk-Taking | 2 | 2006 | 435 | 0.270 |
Why?
|
| Life Style | 3 | 2011 | 288 | 0.260 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 628 | 0.260 |
Why?
|
| Growth Disorders | 1 | 2004 | 22 | 0.260 |
Why?
|
| Students | 3 | 2008 | 452 | 0.250 |
Why?
|
| Health Status | 2 | 2009 | 356 | 0.250 |
Why?
|
| Age Factors | 6 | 2021 | 1007 | 0.250 |
Why?
|
| Social Identification | 1 | 2004 | 49 | 0.240 |
Why?
|
| Gestational Age | 7 | 2011 | 190 | 0.240 |
Why?
|
| Soybean Proteins | 1 | 2004 | 38 | 0.240 |
Why?
|
| Fetal Growth Retardation | 4 | 2010 | 51 | 0.240 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 66 | 0.240 |
Why?
|
| Germ Cells | 2 | 2022 | 70 | 0.230 |
Why?
|
| Fetal Weight | 3 | 2010 | 9 | 0.230 |
Why?
|
| Obstetrics | 3 | 2008 | 38 | 0.230 |
Why?
|
| Retrospective Studies | 10 | 2021 | 1961 | 0.230 |
Why?
|
| Vaccination | 3 | 2023 | 259 | 0.230 |
Why?
|
| Sexual Harassment | 1 | 2002 | 5 | 0.220 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2010 | 33 | 0.220 |
Why?
|
| Arthritis | 1 | 2022 | 16 | 0.220 |
Why?
|
| Acculturation | 1 | 2004 | 172 | 0.220 |
Why?
|
| Chronic Disease | 3 | 2021 | 469 | 0.220 |
Why?
|
| Mexican Americans | 4 | 2010 | 177 | 0.220 |
Why?
|
| Dementia, Multi-Infarct | 1 | 2002 | 1 | 0.220 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 195 | 0.220 |
Why?
|
| Crime Victims | 1 | 2002 | 69 | 0.210 |
Why?
|
| Anemia | 1 | 2002 | 45 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2021 | 19 | 0.210 |
Why?
|
| Poverty | 2 | 2014 | 316 | 0.200 |
Why?
|
| Social Class | 3 | 2017 | 228 | 0.200 |
Why?
|
| Gene Deletion | 1 | 2021 | 156 | 0.200 |
Why?
|
| Population Surveillance | 4 | 2015 | 231 | 0.190 |
Why?
|
| Motivation | 3 | 2023 | 415 | 0.190 |
Why?
|
| Body Height | 1 | 2021 | 52 | 0.190 |
Why?
|
| Social Support | 3 | 2010 | 356 | 0.190 |
Why?
|
| Sex Factors | 3 | 2018 | 859 | 0.190 |
Why?
|
| Models, Genetic | 1 | 2020 | 149 | 0.190 |
Why?
|
| Research Subjects | 1 | 2020 | 31 | 0.190 |
Why?
|
| Family Characteristics | 1 | 2021 | 102 | 0.180 |
Why?
|
| Women's Health | 2 | 2011 | 135 | 0.180 |
Why?
|
| Health Personnel | 2 | 2023 | 200 | 0.180 |
Why?
|
| Logistic Models | 7 | 2010 | 894 | 0.180 |
Why?
|
| Time Factors | 4 | 2018 | 1681 | 0.180 |
Why?
|
| Motor Activity | 2 | 2014 | 393 | 0.180 |
Why?
|
| Mental Health | 1 | 2002 | 270 | 0.170 |
Why?
|
| Dystocia | 3 | 2008 | 5 | 0.170 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 141 | 0.170 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 171 | 0.160 |
Why?
|
| Schools, Medical | 1 | 2020 | 192 | 0.160 |
Why?
|
| Alzheimer Disease | 2 | 2003 | 881 | 0.160 |
Why?
|
| Depression | 2 | 2022 | 664 | 0.160 |
Why?
|
| Prevalence | 4 | 2014 | 1425 | 0.160 |
Why?
|
| Cesarean Section | 2 | 2008 | 53 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 3 | 2022 | 95 | 0.160 |
Why?
|
| Pregnancy Outcome | 3 | 2008 | 90 | 0.160 |
Why?
|
| Body Weight | 2 | 2018 | 404 | 0.160 |
Why?
|
| Menopause | 2 | 2014 | 54 | 0.160 |
Why?
|
| Community-Based Participatory Research | 2 | 2020 | 292 | 0.150 |
Why?
|
| Fetal Macrosomia | 3 | 2007 | 13 | 0.150 |
Why?
|
| Maternal Age | 2 | 2007 | 27 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 36 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2017 | 21 | 0.150 |
Why?
|
| Parenting | 1 | 2018 | 109 | 0.150 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 40 | 0.150 |
Why?
|
| Anthropometry | 4 | 2017 | 91 | 0.150 |
Why?
|
| Bolivia | 2 | 2007 | 9 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 187 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2017 | 188 | 0.140 |
Why?
|
| Birth Weight | 2 | 2006 | 93 | 0.140 |
Why?
|
| Calcium, Dietary | 2 | 2015 | 83 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 371 | 0.140 |
Why?
|
| Tobacco Use Disorder | 1 | 2019 | 229 | 0.140 |
Why?
|
| Twins | 2 | 2006 | 16 | 0.140 |
Why?
|
| Medicare | 1 | 2016 | 188 | 0.130 |
Why?
|
| Epidemiology | 1 | 2014 | 6 | 0.130 |
Why?
|
| Disease | 1 | 2014 | 18 | 0.130 |
Why?
|
| Neoplasms | 2 | 2021 | 1033 | 0.120 |
Why?
|
| Smoking Cessation | 2 | 2019 | 487 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2014 | 98 | 0.120 |
Why?
|
| Diet | 2 | 2021 | 747 | 0.120 |
Why?
|
| Demography | 2 | 2006 | 167 | 0.120 |
Why?
|
| Leukemia | 2 | 2004 | 54 | 0.120 |
Why?
|
| Vitamin D | 1 | 2015 | 176 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2021 | 570 | 0.110 |
Why?
|
| Occupational Exposure | 2 | 2004 | 67 | 0.110 |
Why?
|
| Adolescent Behavior | 2 | 2006 | 243 | 0.110 |
Why?
|
| Insulin | 1 | 2014 | 224 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 303 | 0.110 |
Why?
|
| Smoking | 3 | 2011 | 903 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2011 | 15 | 0.110 |
Why?
|
| Epidemiologic Methods | 3 | 2014 | 44 | 0.100 |
Why?
|
| Germ-Line Mutation | 2 | 2022 | 51 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2008 | 39 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 435 | 0.100 |
Why?
|
| Patient Preference | 1 | 2012 | 46 | 0.100 |
Why?
|
| Universities | 2 | 2020 | 363 | 0.100 |
Why?
|
| Stress, Psychological | 2 | 2008 | 541 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 155 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 12 | 0.100 |
Why?
|
| Parity | 2 | 2008 | 46 | 0.100 |
Why?
|
| Parents | 1 | 2014 | 288 | 0.100 |
Why?
|
| Income | 2 | 2021 | 135 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Infant | 3 | 2014 | 1014 | 0.090 |
Why?
|
| Mass Screening | 1 | 2014 | 427 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2010 | 17 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 247 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2010 | 871 | 0.090 |
Why?
|
| Masculinity | 1 | 2009 | 15 | 0.090 |
Why?
|
| Child Welfare | 1 | 2009 | 34 | 0.090 |
Why?
|
| Fetus | 1 | 2010 | 103 | 0.090 |
Why?
|
| Vaginal Smears | 1 | 2009 | 52 | 0.090 |
Why?
|
| Body Composition | 1 | 2010 | 146 | 0.090 |
Why?
|
| Mother-Child Relations | 1 | 2009 | 55 | 0.090 |
Why?
|
| Exercise | 2 | 2022 | 524 | 0.090 |
Why?
|
| Health Facility Environment | 1 | 2008 | 4 | 0.090 |
Why?
|
| Noise | 1 | 2008 | 5 | 0.090 |
Why?
|
| China | 3 | 2004 | 178 | 0.090 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 44 | 0.080 |
Why?
|
| Fetal Distress | 1 | 2008 | 4 | 0.080 |
Why?
|
| Fetal Monitoring | 1 | 2008 | 5 | 0.080 |
Why?
|
| Bibliometrics | 1 | 2008 | 16 | 0.080 |
Why?
|
| Heart Rate, Fetal | 1 | 2008 | 12 | 0.080 |
Why?
|
| Publishing | 1 | 2008 | 25 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2008 | 82 | 0.080 |
Why?
|
| Monocytes | 1 | 2010 | 258 | 0.080 |
Why?
|
| Group Practice | 1 | 2008 | 8 | 0.080 |
Why?
|
| Research Design | 2 | 2008 | 292 | 0.080 |
Why?
|
| Hospitals, Community | 1 | 2008 | 13 | 0.080 |
Why?
|
| Paraguay | 1 | 2007 | 1 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2021 | 628 | 0.080 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2007 | 1 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 233 | 0.080 |
Why?
|
| Health Surveys | 2 | 2010 | 358 | 0.080 |
Why?
|
| Birth Injuries | 1 | 2007 | 9 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2018 | 1318 | 0.080 |
Why?
|
| Abdomen | 2 | 2006 | 12 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2007 | 23 | 0.080 |
Why?
|
| Gene Frequency | 2 | 2017 | 155 | 0.070 |
Why?
|
| Shoulder | 1 | 2006 | 9 | 0.070 |
Why?
|
| Birth Order | 1 | 2006 | 5 | 0.070 |
Why?
|
| Proxy | 1 | 2006 | 7 | 0.070 |
Why?
|
| Washington | 1 | 2006 | 28 | 0.070 |
Why?
|
| Pregnancy, High-Risk | 1 | 2006 | 5 | 0.070 |
Why?
|
| Contraception | 1 | 2007 | 57 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2017 | 159 | 0.070 |
Why?
|
| Decision Making | 2 | 2023 | 189 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2006 | 151 | 0.070 |
Why?
|
| Agriculture | 1 | 2006 | 45 | 0.070 |
Why?
|
| Gynecology | 1 | 2006 | 31 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 92 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 62 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1152 | 0.070 |
Why?
|
| Leptin | 1 | 2007 | 115 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2006 | 52 | 0.070 |
Why?
|
| Acid-Base Imbalance | 1 | 2005 | 3 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2005 | 19 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2005 | 33 | 0.070 |
Why?
|
| Infant Welfare | 1 | 2004 | 7 | 0.070 |
Why?
|
| Social Values | 1 | 2005 | 30 | 0.070 |
Why?
|
| Sexual Behavior | 3 | 2005 | 587 | 0.070 |
Why?
|
| Maternal Behavior | 1 | 2004 | 22 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2008 | 613 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 310 | 0.060 |
Why?
|
| Chorion | 1 | 2004 | 8 | 0.060 |
Why?
|
| Infant Mortality | 3 | 2014 | 57 | 0.060 |
Why?
|
| Spouse Abuse | 1 | 2004 | 43 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2010 | 429 | 0.060 |
Why?
|
| Comorbidity | 2 | 2007 | 606 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 22 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2005 | 99 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2003 | 8 | 0.060 |
Why?
|
| Occupations | 1 | 2003 | 20 | 0.060 |
Why?
|
| Hazardous Substances | 1 | 2003 | 18 | 0.060 |
Why?
|
| Placenta | 1 | 2004 | 91 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 555 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2011 | 115 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 2 | 2016 | 27 | 0.060 |
Why?
|
| Data Collection | 1 | 2004 | 188 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2017 | 32 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2005 | 159 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2003 | 92 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2006 | 358 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2023 | 44 | 0.060 |
Why?
|
| Genes, BRCA2 | 1 | 2022 | 6 | 0.050 |
Why?
|
| Attitude | 1 | 2023 | 97 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 424 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 170 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2002 | 70 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2002 | 91 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 81 | 0.050 |
Why?
|
| Violence | 1 | 2002 | 126 | 0.050 |
Why?
|
| Africa | 1 | 2021 | 62 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 88 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 128 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2020 | 24 | 0.050 |
Why?
|
| Emotions | 1 | 2023 | 204 | 0.050 |
Why?
|
| Cause of Death | 1 | 2021 | 154 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 901 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 269 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2020 | 110 | 0.050 |
Why?
|
| Oligohydramnios | 2 | 2011 | 4 | 0.050 |
Why?
|
| Group Processes | 1 | 2019 | 21 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2002 | 285 | 0.040 |
Why?
|
| Trust | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 119 | 0.040 |
Why?
|
| Labor, Obstetric | 2 | 2008 | 15 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2002 | 418 | 0.040 |
Why?
|
| Educational Status | 2 | 2012 | 295 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2017 | 10 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2020 | 328 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2017 | 18 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 36 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 97 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 58 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 60 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2016 | 123 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 68 | 0.040 |
Why?
|
| Biopsy | 1 | 2016 | 151 | 0.040 |
Why?
|
| Overweight | 2 | 2010 | 233 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 342 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 115 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 705 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 56 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 1802 | 0.030 |
Why?
|
| Pesticides | 2 | 2006 | 44 | 0.030 |
Why?
|
| Health Behavior | 2 | 2011 | 491 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2015 | 196 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2012 | 14 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2012 | 15 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 2011 | 2 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 44 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2012 | 61 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2012 | 56 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 707 | 0.030 |
Why?
|
| Sample Size | 1 | 2010 | 28 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 23 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 356 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 74 | 0.020 |
Why?
|
| Public Assistance | 1 | 2010 | 26 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 54 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2010 | 1 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 14 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 38 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 24 | 0.020 |
Why?
|
| Calpain | 1 | 2010 | 31 | 0.020 |
Why?
|
| Ion Channels | 1 | 2010 | 69 | 0.020 |
Why?
|
| Peer Group | 1 | 2010 | 138 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2010 | 316 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 96 | 0.020 |
Why?
|
| Trial of Labor | 1 | 2008 | 1 | 0.020 |
Why?
|
| Apgar Score | 1 | 2008 | 5 | 0.020 |
Why?
|
| Labor Stage, Second | 1 | 2008 | 2 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 14 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 111 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 57 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 145 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 131 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 48 | 0.020 |
Why?
|
| Patient Admission | 1 | 2008 | 40 | 0.020 |
Why?
|
| Clavicle | 1 | 2007 | 3 | 0.020 |
Why?
|
| Shoulder Fractures | 1 | 2007 | 2 | 0.020 |
Why?
|
| Humeral Fractures | 1 | 2007 | 3 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 639 | 0.020 |
Why?
|
| Heart Rate | 1 | 2008 | 248 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2007 | 51 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2006 | 7 | 0.020 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 10 | 0.020 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 4 | 0.020 |
Why?
|
| SEER Program | 1 | 2006 | 87 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2006 | 46 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 78 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 196 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 33 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 445 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2005 | 3 | 0.020 |
Why?
|
| Illegitimacy | 1 | 2005 | 1 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 75 | 0.020 |
Why?
|
| Sex Education | 1 | 2005 | 29 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2005 | 47 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2004 | 5 | 0.020 |
Why?
|
| Empathy | 1 | 2004 | 26 | 0.020 |
Why?
|
| Unemployment | 1 | 2004 | 23 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 8 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 37 | 0.020 |
Why?
|
| Benzene | 1 | 2004 | 13 | 0.020 |
Why?
|
| Linear Models | 1 | 2005 | 253 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2004 | 212 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2004 | 35 | 0.020 |
Why?
|
| Chemical Industry | 1 | 2003 | 1 | 0.010 |
Why?
|
| Solvents | 1 | 2004 | 93 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2006 | 250 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 210 | 0.010 |
Why?
|
| Family | 1 | 2004 | 162 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 685 | 0.010 |
Why?
|
| Iron, Dietary | 1 | 2002 | 13 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 111 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 2002 | 42 | 0.010 |
Why?
|
| India | 1 | 2002 | 82 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 1349 | 0.010 |
Why?
|
| Sexual Partners | 1 | 2005 | 308 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 114 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 490 | 0.010 |
Why?
|
| Rural Population | 1 | 2002 | 253 | 0.010 |
Why?
|